Program

Friday, September 25, 2020

Cirrhosis and portal hypertension: 

from guidelines to individualized approach


08:30   OPENING CEREMONY (Ljubičić N, Ostojić R, Tonkić A, Dolic K, Flisiak R, Puljiz Z, Grgurević I)

09:00-10:30   RECOGNIZING THE PROBLEM

Chairs: Ostojic R, Puljiz Z

Noninvasive tests for fibrosis and cirrhosis: are we ready for screening? (Gines P , ES)

What about steatosis and NAFLD? (Mikolasevic I, HR)

Noninvasive tests of portal hypertension by elastography (Grgurevic I, HR)

How close we are to HCV elimination: data from Central Europe (Flisiak R, PL)

11:00-12:30   PREVENTING THE COMPLICATIONS

Chairs: Flisiak R, Tonkic A

Primary prevention of variceal bleeding and decompensation (Bosch J, ES)

Gut microbioma in progression of cirrhosis and portal hypertension (Papp M, HU)

Treatment of hepatitis C in patients with cirrhosis (Filipec-Kanizaj T, HR)

Treatment of PBC (Jarcuska P, SK)

13:30-15:00   PATIENT WITH ADVANCED CIRRHOSIS AND PORTAL HYPERTENSION I

Chairs: Villanueva C, Milic S

Endoscopic treatment of acute variceal bleeding (Puljiz Z, HR)

Secondary prevention of variceal bleeding: guided or blinded? (Alvarado TE, ES)

The role of TIPS (Patch D/Potts J, UK)

Renal injury in cirrhosis (Knezevic-Stromar I, HR)

15:30-17:00   PATIENT WITH ADVANCED CIRRHOSIS AND PORTAL HYPERTENSION II

Chairs: Hrstic I, Sperl I

Frailty in cirrhosis (Skladany L, SK)

Severe alcoholic hepatitis (Virovic Jukic L, HR)

Long-term outcome of patients with alcoholic liver cirrhosis (Stauber R, AT)

Impact of outpatient care on survival in alcoholic cirrhosis (Tepes B, SI)

17:30-19:00   PERSONALIZED AND PRECISION MEDICINE IN CIRRHOSIS AND PH

Chairs: Bonacin D, Graupera I

Genetic determinants for progression of cirrhosis and portal hypertension (Tsochatzis E, UK)

A new prognostic algorithm to improve risk-stratification after variceal bleeding (La Mura, IT)

Artificial neural network prognostic modeling in cirrhosis (Salkic N, BA)

Screening for HCC (Milovanovic T, RS)

19:00 CLOSING REMARKS